Shiyu Xiao

1.3k total citations · 1 hit paper
33 papers, 846 citations indexed

About

Shiyu Xiao is a scholar working on Surgery, Rheumatology and Immunology. According to data from OpenAlex, Shiyu Xiao has authored 33 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Rheumatology and 7 papers in Immunology. Recurrent topics in Shiyu Xiao's work include Helicobacter pylori-related gastroenterology studies (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Shiyu Xiao is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Shiyu Xiao collaborates with scholars based in China, Sweden and United States. Shiyu Xiao's co-authors include Liya Zhou, Wenhui Xie, Zhuoli Zhang, Xiaoying Sun, Yong Fan, Yang Yu, Lin Qiu, Yu Wang, Hong Huang and Liya Zhou and has published in prestigious journals such as The American Journal of Medicine, BMJ and Frontiers in Immunology.

In The Last Decade

Shiyu Xiao

27 papers receiving 833 citations

Hit Papers

Association of gestational diabetes mellitus with overall... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiyu Xiao China 15 219 214 192 173 138 33 846
Laurette Geldenhuys Canada 18 339 1.5× 213 1.0× 177 0.9× 84 0.5× 104 0.8× 43 853
Jianhui Zhang China 18 498 2.3× 259 1.2× 333 1.7× 115 0.7× 108 0.8× 83 1.1k
Şennur İlvan Türkiye 19 131 0.6× 206 1.0× 212 1.1× 71 0.4× 153 1.1× 78 1.1k
Yuki Kojima Japan 17 207 0.9× 177 0.8× 379 2.0× 62 0.4× 149 1.1× 104 983
Sally Self United States 20 207 0.9× 351 1.6× 211 1.1× 185 1.1× 114 0.8× 55 1.2k
Tzong‐Shin Tzai Taiwan 21 418 1.9× 425 2.0× 253 1.3× 71 0.4× 252 1.8× 81 1.2k
Monica Attanasio Italy 20 155 0.7× 207 1.0× 104 0.5× 56 0.3× 215 1.6× 44 1.1k
Jesús Romero Spain 16 364 1.7× 193 0.9× 340 1.8× 100 0.6× 335 2.4× 62 1.0k
Mercedes Gómez‐Morales Spain 17 382 1.7× 102 0.5× 306 1.6× 102 0.6× 154 1.1× 46 1.0k

Countries citing papers authored by Shiyu Xiao

Since Specialization
Citations

This map shows the geographic impact of Shiyu Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyu Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyu Xiao more than expected).

Fields of papers citing papers by Shiyu Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyu Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyu Xiao. The network helps show where Shiyu Xiao may publish in the future.

Co-authorship network of co-authors of Shiyu Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyu Xiao. A scholar is included among the top collaborators of Shiyu Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyu Xiao. Shiyu Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Wenhui, Tong Chen, Shiyu Xiao, Hong Huang, & Zhuoli Zhang. (2025). Difficult-to-treat rheumatoid arthritis: systematic review and meta-analysis on global prevalence. Annals of the Rheumatic Diseases. 85(3). 417–424.
3.
Li, Anyuan, et al.. (2024). Trends in incidence, treatment modalities and prognosis of esophageal adenocarcinoma in the US population. Cancer Epidemiology. 93. 102683–102683.
4.
Xie, Wenhui, et al.. (2024). Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor–Inhibitor Treatment for Autoimmune Diseases. JAMA Neurology. 81(12). 1284–1284. 9 indexed citations
5.
Xiao, Shiyu, et al.. (2024). Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis. The American Journal of Medicine. 137(11). 1072–1081.e32. 6 indexed citations
6.
Xiao, Shiyu, et al.. (2023). The Immune Landscape and Molecular Subtypes of Pediatric Crohn’s Disease: Results from In Silico Analysis. Journal of Personalized Medicine. 13(4). 571–571. 5 indexed citations
7.
Xie, Wenhui, et al.. (2023). Incidence, mortality, and risk factors of acute kidney injury after immune checkpoint inhibitors: Systematic review and meta-analysis of real-world evidence. European Journal of Internal Medicine. 115. 88–95. 12 indexed citations
8.
Xiao, Shiyu, et al.. (2022). Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1865(6). 194829–194829. 8 indexed citations
9.
Xiao, Shiyu, et al.. (2022). The necessity and appropriate range of the diagnostic “gray zone” of 13C-urea breath test. Saudi Journal of Gastroenterology. 28(5). 385–392.
10.
Xie, Wenhui, Shiyu Xiao, Hong Huang, & Zhuoli Zhang. (2022). Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis. Frontiers in Immunology. 13. 847160–847160. 16 indexed citations
11.
Xiao, Shiyu, Baojun Suo, Ye Wang, et al.. (2021). The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults. Helicobacter. 26(6). e12848–e12848. 48 indexed citations
12.
13.
Xiao, Shiyu, et al.. (2021). Long-Term Outcome of Gastric Mild-Moderate Dysplasia: A Real-World Clinical Experience. Clinical Gastroenterology and Hepatology. 20(6). 1259–1268.e7. 6 indexed citations
14.
Xiao, Shiyu, Wenhui Xie, & Liya Zhou. (2020). Mucosal chemokine CXCL17: What is known and not known. Scandinavian Journal of Immunology. 93(2). e12965–e12965. 28 indexed citations
15.
Xiao, Shiyu, et al.. (2020). Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 36(1). 55–63. 19 indexed citations
16.
Xie, Wenhui, Hong Huang, Shiyu Xiao, Xinlei Yang, & Zhuoli Zhang. (2020). Effect of statin use on cardiovascular events and all-cause mortality in immune-mediated inflammatory diseases: A systematic review and meta-analysis involving 148,722 participants. Pharmacological Research. 160. 105057–105057. 13 indexed citations
17.
Xiao, Shiyu, et al.. (2020). Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome. Annals of Translational Medicine. 8(15). 937–937. 37 indexed citations
18.
Xiao, Shiyu & Liya Zhou. (2020). Gastric Stem Cells: Physiological and Pathological Perspectives. Frontiers in Cell and Developmental Biology. 8. 571536–571536. 57 indexed citations
19.
Xie, Wenhui, Shiyu Xiao, Xiaoying Sun, et al.. (2019). A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy. Lara D. Veeken. 59(5). 930–939. 30 indexed citations
20.
Jiang, Wenjun, Liya Zhou, Sanren Lin, et al.. (2018). Metabolic profiles of gastric cancer cell lines with different degrees of differentiation.. PubMed. 11(2). 869–875. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026